Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung
Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer.